Safety and efficacy of persistent atrial fibrillation ablation using the second-generation cryoballoon

2018 ◽  
Vol 107 (7) ◽  
pp. 570-577 ◽  
Author(s):  
Kivanc Yalin ◽  
Amr Abdin ◽  
Evgeny Lyan ◽  
Noureddin Sawan ◽  
Spyridon Liosis ◽  
...  
EP Europace ◽  
2018 ◽  
Vol 20 (suppl_1) ◽  
pp. i206-i206 ◽  
Author(s):  
K Yalin ◽  
E Lyan ◽  
A Abdin ◽  
N Sawan ◽  
C Eitel ◽  
...  

2015 ◽  
Vol 26 (12) ◽  
pp. 1315-1320 ◽  
Author(s):  
SONIA AMMAR-BUSCH ◽  
BERNHARD M. KAESS ◽  
ALEXANDRA BRUHM ◽  
TILKO REENTS ◽  
FELIX BOURIER ◽  
...  

2019 ◽  
Vol 125 (6) ◽  
pp. 609-627 ◽  
Author(s):  
Jorge G. Quintanilla ◽  
José Manuel Alfonso-Almazán ◽  
Nicasio Pérez-Castellano ◽  
Sandeep V. Pandit ◽  
José Jalife ◽  
...  

2018 ◽  
Vol 2 (47) ◽  
pp. 16-21
Author(s):  
Grzegorz Hordyński ◽  
Agnieszka Wojdyła-Hordyńska

Since the release of the second-generation cryoballoon (CB2; Arctic Front AdvanceTM, Medtronic Inc) and its modifications with improved cooling characteristics, the technique, dosing, and complication profile is significantly different from that of the first-generation cryoballoon. Several reports of CB2 procedural recommendations have been presented. Hereby, the literature summary was performed and the technical and procedural study based regimen delivered. The best practice overview presents large centers contemporary techniques for safer and more effective outcomes and perhaps new approved recommendations for atrial fibrillation treatment.


Sign in / Sign up

Export Citation Format

Share Document